Skip to content

BIOSPECIFICS TECHNOLOGIES CORP: 10-K filed 2013-03-15

What BIOSPECIFICS TECHNOLOGIES CORP reported in its annual report filed 2013-03-15 (fiscal FY 2012): 37 published measures, 138 facts as tagged in accession 0001140361-13-012763.

This filing

Form
10-K (annual report)
Filed
2013-03-15
Fiscal period
fiscal FY 2012
Accession
0001140361-13-012763 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOSPECIFICS TECHNOLOGIES CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3118,390,264USD
At 2011-12-3116,265,073USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3117,458,346USD
At 2011-12-3114,872,314USD
At 2010-12-316,700,723USD
At 2009-12-316,092,107USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-313,383,737USD
At 2011-12-313,196,831USD
At 2010-12-312,470,852USD
At 2009-12-313,950,389USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-311,100,956USD92
2012-01-01 to 2012-12-312,981,075USD366
2012-07-01 to 2012-09-30471,047USD92
2012-04-01 to 2012-06-30666,682USD91
2012-01-01 to 2012-03-31742,390USD91
2011-10-01 to 2011-12-3171,326USD92
2011-01-01 to 2011-12-316,601,626USD365
2011-07-01 to 2011-09-30268,836USD92
2011-04-01 to 2011-06-302,569,341USD91
2011-01-01 to 2011-03-313,691,123USD90
2010-01-01 to 2010-12-31-1,508,540USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,430,433USD366
2011-01-01 to 2011-12-31-687,589USD365
2010-01-01 to 2010-12-31-882,482USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-623,527USD366
2011-01-01 to 2011-12-311,052,598USD365
2010-01-01 to 2010-12-31215,374USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1,620,000USD366
2011-01-01 to 2011-12-31360,970USD365
2010-01-01 to 2010-12-31-812,429USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-310,829USD
At 2011-12-31-3,291,904USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-01-01 to 2012-12-316,351,245shares366
2011-01-01 to 2011-12-316,340,648shares365
2010-01-01 to 2010-12-316,261,214shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-01-01 to 2012-12-316,981,527shares366
2011-01-01 to 2011-12-316,952,386shares365
2010-01-01 to 2010-12-316,261,214shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-10-01 to 2012-12-310.17USD/shares92
2012-01-01 to 2012-12-310.47USD/shares366
2012-07-01 to 2012-09-300.07USD/shares92
2012-04-01 to 2012-06-300.11USD/shares91
2012-01-01 to 2012-03-310.12USD/shares91
2011-10-01 to 2011-12-310.01USD/shares92
2011-01-01 to 2011-12-311.04USD/shares365
2011-07-01 to 2011-09-300.04USD/shares92
2011-04-01 to 2011-06-300.4USD/shares91
2011-01-01 to 2011-03-310.59USD/shares90
2010-01-01 to 2010-12-31-0.24USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-10-01 to 2012-12-310.16USD/shares92
2012-01-01 to 2012-12-310.43USD/shares366
2012-07-01 to 2012-09-300.07USD/shares92
2012-04-01 to 2012-06-300.1USD/shares91
2012-01-01 to 2012-03-310.11USD/shares91
2011-10-01 to 2011-12-310.01USD/shares92
2011-01-01 to 2011-12-310.95USD/shares365
2011-07-01 to 2011-09-300.04USD/shares92
2011-04-01 to 2011-06-300.36USD/shares91
2011-01-01 to 2011-03-310.51USD/shares90
2010-01-01 to 2010-12-31-0.24USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,174,054USD366
2011-01-01 to 2011-12-31-1,338,256USD365
2010-01-01 to 2010-12-311,351USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-310USD
At 2010-12-310USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-31228,485USD366
2011-01-01 to 2011-12-31517,367USD365
2010-01-01 to 2010-12-311,901,781USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-312,044,932USD92
2012-01-01 to 2012-12-315,120,495USD366
2012-07-01 to 2012-09-30779,527USD92
2012-04-01 to 2012-06-301,047,562USD91
2012-01-01 to 2012-03-311,248,474USD91
2011-10-01 to 2011-12-311,284,335USD92
2011-01-01 to 2011-12-315,191,767USD365
2011-07-01 to 2011-09-30452,100USD92
2011-04-01 to 2011-06-303,320,009USD91
2011-01-01 to 2011-03-31135,323USD90
2010-01-01 to 2010-12-31-2,033,032USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3113,875,801USD
At 2011-12-3113,086,503USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-31724,528USD
At 2011-12-311,116,239USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-315,082,360USD
At 2011-12-313,236,917USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,034,647USD366
2011-01-01 to 2011-12-31739,551USD365
2010-01-01 to 2010-12-31458,001USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,249,755USD366
2011-01-01 to 2011-12-31972,078USD365
2010-01-01 to 2010-12-311,223,931USD365

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-3120,688,706USD
At 2011-12-3120,049,196USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-311,839,597USD
At 2011-12-311,839,597USD
At 2010-12-311,839,597USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-311,839,597USD
At 2011-12-311,839,597USD
At 2010-12-311,839,597USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-12-31280,322USD
At 2011-12-31190,416USD
At 2010-12-31173,443USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-31149,724USD
At 2011-12-3198,234USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-311,573,050USD
At 2011-12-313,047,955USD
At 2010-12-310USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,155,129USD366
2011-01-01 to 2011-12-315,263,370USD365
2010-01-01 to 2010-12-31-1,507,189USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,774,828USD366
2011-01-01 to 2011-12-315,231,881USD365
2010-01-01 to 2010-12-316,470,449USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2011-01-01 to 2011-12-310USD365
2010-01-01 to 2010-12-310USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-3164,190USD366
2011-01-01 to 2011-12-3150,685USD365
2010-01-01 to 2010-12-3118,949USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-01-01 to 2012-12-3164,190USD366
2011-01-01 to 2011-12-3150,685USD365
2010-01-01 to 2010-12-3136,041USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2011-01-01 to 2011-12-3115,823USD365
2010-01-01 to 2010-12-3113,130USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-3134,634USD366
2011-01-01 to 2011-12-3171,603USD365
2010-01-01 to 2010-12-31525,843USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2012-01-01 to 2012-12-31699,150USD366
2011-01-01 to 2011-12-313,525USD365
2010-01-01 to 2010-12-311,351USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,474,904USD366
2011-01-01 to 2011-12-31-1,341,783USD365
2010-01-01 to 2010-12-310USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,845,443USD366
2011-01-01 to 2011-12-311,250,792USD365
2010-01-01 to 2010-12-31459,291USD365

Inspect the source

Entity
BIOSPECIFICS TECHNOLOGIES CORP / CIK 0000875622
Captured
SEC response SHA-256
b1d443fa8a2de5e07d7cbcf40e33944d546011c718a394f04bbb863281862def

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000875622.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))